RVL Pharmaceuticals plc (RVLPQ)
RVLPQ Stock Price Chart
Explore RVL Pharmaceuticals plc interactive price chart. Choose custom timeframes to analyze RVLPQ price movements and trends.
RVLPQ Company Profile
Discover essential business fundamentals and corporate details for RVL Pharmaceuticals plc (RVLPQ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Oct 2018
Employees
125.00
Website
https://www.rvlpharma.comCEO
Brian A. Markison
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
RVLPQ Financial Timeline
Browse a chronological timeline of RVL Pharmaceuticals plc corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 1 Apr 2025
Earnings released on 27 Mar 2025
Earnings released on 1 Nov 2024
Earnings released on 26 Sept 2024
Earnings released on 10 May 2024
Earnings released on 12 Feb 2024
Earnings released on 29 Dec 2023
Earnings released on 30 Jun 2023
EPS came in at -$0.24 falling short of the estimated -$0.11 by -114.64%, while revenue for the quarter reached $8.26M , missing expectations by -22.30%.
Earnings released on 31 Mar 2023
EPS came in at -$0.12 surpassing the estimated -$0.12 by +2.09%, while revenue for the quarter reached $8.83M , missing expectations by -5.72%.
Earnings released on 31 Dec 2022
EPS came in at -$0.18 falling short of the estimated -$0.17 by -8.68%, while revenue for the quarter reached $9.81M , missing expectations by -21.92%.
Earnings released on 29 Sept 2022
EPS came in at -$0.16 surpassing the estimated -$0.16 by +2.49%, while revenue for the quarter reached $10.02M , beating expectations by +0.01%.
Earnings released on 29 Jun 2022
EPS came in at -$0.14 , while revenue for the quarter reached $8.45M .
Earnings released on 30 Mar 2022
EPS came in at -$0.08 surpassing the estimated -$0.24 by +66.42%, while revenue for the quarter reached $21.44M , beating expectations by +155.72%.
Earnings released on 30 Dec 2021
EPS came in at -$0.24 , while revenue for the quarter reached $2.86M .
Earnings released on 29 Sept 2021
EPS came in at -$0.35 , while revenue for the quarter reached $2.20M .
RVLPQ Stock Performance
Access detailed RVLPQ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.